People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stratos Genomics Inc. | — | Biotechnology | Series B | $58.9M | $800.0M | 2010 |
| Singulex Inc | — | Biotechnology | Series B | $44.7M | $483.8M | 2011 |
| Senet, Inc. | — | Other Technology | Series A | $36.8M | $326.1M | 2015 |
Stephen Rose at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Rose on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Heiner Dreismann | 2 | 6 |
| Carl Gordon | 1 | 24 |
| Gregory Johnson | 1 | 8 |
| CARL L. GORDON | 1 | 7 |
| Lee Huntsman | 1 | 5 |
| Todd Warden | 1 | 5 |
| Hironori Hozoji | 1 | 4 |
| Gregory R. Johnson | 1 | 3 |
| Richard Dumler | 1 | 3 |
| Ted Krantz | 1 | 2 |
| RICHARD GIBBS | 1 | 2 |
| Tom Groos | 1 | 2 |
| Allan Stephan | 1 | 2 |
| Harold Kawaguchi | 1 | 2 |
| Stephen L. Rose | 1 | 2 |
| Theodore Krantz | 1 | 1 |
| Peter B. Hunt | 1 | 1 |
| George Dannecker | 1 | 1 |
| Tom Gross | 1 | 1 |
| Steve Owens | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.